Page last updated: 2024-11-04

risedronic acid and Recrudescence

risedronic acid has been researched along with Recrudescence in 5 studies

Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.

Research Excerpts

ExcerptRelevanceReference
"Although etidronate is effective, risedronate offers a shorter duration of therapy, better and longer-lasting remission, significant reductions in pain, and provides additional remission in subjects who exhibited an incomplete response to previous etidronate treatment."5.09A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group. ( Axelrod, DW; Bekker, PJ; Brown, JP; Hoseyni, MS; Miller, PD; Siris, ES, 1999)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hemmati, I1
Wade, J1
Kelsall, J1
Baranauskaite, A1
Kanis, JA1
Barton, IP1
Johnell, O1
Hosking, DJ1
Miller, PD1
Brown, JP1
Siris, ES1
Hoseyni, MS1
Axelrod, DW1
Bekker, PJ1

Reviews

3 reviews available for risedronic acid and Recrudescence

ArticleYear
Risedronate-associated scleritis: a case report and review of the literature.
    Clinical rheumatology, 2012, Volume: 31, Issue:9

    Topics: Adrenal Cortex Hormones; Aged; Brain; China; Diphosphonates; Etidronic Acid; Female; Humans; Inflamm

2012
[Osteoporosis: diagnosis and treatment of vertebral fractures].
    Medicina (Kaunas, Lithuania), 2002, Volume: 38, Issue:8

    Topics: Age Factors; Aged; Calcium; Calcium Channel Blockers; Etidronic Acid; Female; Humans; Male; Middle A

2002
Prediction and assessment of the response of Paget's disease to bisphosphonate treatment.
    Bone, 1999, Volume: 24, Issue:5 Suppl

    Topics: Alkaline Phosphatase; Bone Resorption; Diphosphonates; Etidronic Acid; Half-Life; Humans; Osteitis D

1999

Trials

2 trials available for risedronic acid and Recrudescence

ArticleYear
Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2005, Volume: 16, Issue:5

    Topics: Absorptiometry, Photon; Aged; Anthropometry; Bone Density; Double-Blind Method; Etidronic Acid; Fema

2005
A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group.
    The American journal of medicine, 1999, Volume: 106, Issue:5

    Topics: Administration, Oral; Aged; Alkaline Phosphatase; Bone and Bones; Calcium Channel Blockers; Double-B

1999